Jan-Christoph Simon Selected Research

Jan-Christoph Simon Research Topics

Disease

12	Melanoma (Melanoma, Malignant) 07/2021 - 06/2009
4	Hypersensitivity (Allergy) 01/2022 - 07/2015
3	Wounds and Injuries (Trauma) 01/2022 - 05/2021
3	Neoplasms (Cancer) 11/2021 - 05/2016
3	Infections 11/2021 - 01/2020
3	Neoplasm Metastasis (Metastasis) 11/2019 - 06/2009
2	Angioedema 01/2021 - 05/2010
2	Drug Eruptions (Drug Eruption) 01/2019 - 12/2017
2	Anaphylaxis (Anaphylactic Shock) 02/2018 - 06/2017
1	Ulcer 01/2022
1	Hypertrophic Cicatrix (Hypertrophic Scar) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Cicatrix (Scar) 01/2022
1	Eczema 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2021
1	Atopic Dermatitis (Atopic Eczema) 10/2021
1	Food Hypersensitivity (Food Allergy) 09/2021
1	Peanut Hypersensitivity (Peanut Allergy) 09/2021
1	Anxiety Disorders (Anxiety Disorder) 01/2021
1	Lipoma (Lipomata) 01/2021
1	Obesity 01/2021
1	Pain (Aches) 10/2020
1	Pancreatitis 10/2019
1	Disease Progression 05/2019
1	Drug-Related Side Effects and Adverse Reactions 05/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Merkel Cell Carcinoma 01/2019
1	Polyneuropathies (Polyneuropathy) 02/2018
1	Lichen Planus (Lichen Ruber Planus) 12/2017
1	Arteriovenous Fistula 11/2017
1	Flushing 11/2017
1	Neoplasm Micrometastasis 06/2016
1	Respiratory Tract Diseases (Respiratory Tract Disease) 08/2015
1	Sleep Wake Disorders 07/2015
1	Vascular Diseases (Vascular Disease) 07/2015
1	Agranulocytosis (Granulocytopenia) 08/2014
1	Chronic Urticaria 08/2014
1	Pigmented Nevus (Melanocytic Nevus) 09/2013
1	Skin Diseases (Skin Disease) 06/2012
1	Cutaneous Lupus Erythematosus 01/2011
1	Urticaria (Hives) 05/2010
1	Acute Generalized Exanthematous Pustulosis 01/2009

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2020 - 01/2019
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2022 - 01/2021
2	Immunoglobulin E (IgE)IBA 01/2022 - 09/2021
2	AllergensIBA 09/2021 - 01/2017
2	IpilimumabIBA 01/2020 - 05/2016
1	Arthropod VenomsIBA 01/2022
1	Alcian BlueIBA 01/2022
1	C.I. direct red 80IBA 01/2022
1	CollagenIBA 01/2022
1	Biological ProductsIBA 11/2021
1	secukinumabIBA 11/2021
1	Interleukin-17 (Interleukin 17)IBA 11/2021
1	dupilumabIBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	Immune Checkpoint InhibitorsIBA 07/2021
1	HydrogelsIBA 05/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	LipidsIBA 01/2021
1	ORALIT (ORS)IBA 10/2020
1	SteroidsIBA 01/2020
1	NivolumabIBA 01/2020
1	VemurafenibIBA 10/2019
1	Dacarbazine (DIC)FDA LinkGeneric 10/2019
1	Messenger RNA (mRNA)IBA 10/2019
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	avelumabIBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Drug CombinationsIBA 01/2019
1	Thiamine (Aneurin)FDA Link 02/2018
1	thiamine hydrochloride FDA LinkGeneric 02/2018
1	Heparin (Liquaemin)FDA LinkGeneric 11/2017
1	Cefuroxime (Zinacef)FDA LinkGeneric 06/2017
1	InflammasomesIBA 08/2015
1	Retinaldehyde (Retinal)IBA 07/2015
1	Genetic Markers (Genetic Marker)IBA 07/2015
1	Dapsone FDA Link 08/2014
1	Melanins (Melanin)IBA 09/2013
1	Hyaluronic Acid (Hyaluronan)IBA 06/2012
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 06/2012
1	GlycosaminoglycansIBA 06/2012
1	Simvastatin (Zocor)FDA LinkGeneric 01/2011
1	InterferonsIBA 05/2010
1	Imiquimod (Aldara)FDA LinkGeneric 06/2009
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2009

Therapy/Procedure

12	Therapeutics 11/2021 - 06/2009
3	Radiotherapy 01/2022 - 05/2019
3	Immunotherapy 09/2021 - 05/2019
2	Lymph Node Excision (Lymph Node Dissection) 11/2019 - 06/2016
2	Drug Therapy (Chemotherapy) 10/2019 - 05/2019
1	Skin Transplantation (Skin Grafting) 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Emergency Treatment 09/2021
1	Injections 05/2021
1	Intramuscular Injections 02/2018
1	Vascular Access Devices (Arterial Line) 11/2017
1	Complementary Therapies (Alternative Medicine) 05/2016
1	Lasers (Laser) 09/2013
1	Hair Removal (Depilation) 09/2013